KRYSTAL BIOTECH OUTLINES $175M-$195M 2026 NON-GAAP OPEX RANGE AS VYJUVEK EXPANDS OVERSEAS PRICING TALKS - SEEKINGALPHA
KRYSTAL BIOTECH OUTLINES $175M-$195M 2026 NON-GAAP OPEX RANGE AS VYJUVEK EXPANDS OVERSEAS PRICING TALKS - SEEKINGALPHA
What changed
KRYSTAL BIOTECH OUTLINES $175M-$195M 2026 NON-GAAP OPEX RANGE AS VYJUVEK EXPANDS OVERSEAS PRICING TALKS - SEEKINGALPHA
Why it matters
KRYSTAL BIOTECH OUTLINES $175M-$195M 2026 NON-GAAP OPEX RANGE AS VYJUVEK EXPANDS OVERSEAS PRICING TALKS - SEEKINGALPHA — impact context not separately stored; see What changed.
← Dashboard
Aug 03, 2026 06:21 PM ET